img

Global Peptides Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Peptides Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Peptides report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Peptides market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Diabetes and Infectious Diseases are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Peptides industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Peptides key manufacturers include Cipla Ltd., Emcure Pharmaceuticals Pvt. Ltd., Gland Pharma Limited, Troikaa Pharmaceuticals Ltd., Biological E Limited, Bharat Biotech, Samarth Life Sciences Pvt. Ltd., VHB Life Sciences Limited and Celon Laboratories Pvt. Ltd., etc. Cipla Ltd., Emcure Pharmaceuticals Pvt. Ltd., Gland Pharma Limited are top 3 players and held % sales share in total in 2022.
Peptides can be divided into Insulin, Teriparatide, Liraglutide and Leuprolide, etc. Insulin is the mainstream product in the market, accounting for % sales share globally in 2022.
Peptides is widely used in various fields, such as Diabetes, Infectious Diseases, Cancer and Osteoporosis, etc. Diabetes provides greatest supports to the Peptides industry development. In 2022, global % sales of Peptides went into Diabetes filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Peptides market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Cipla Ltd.
Emcure Pharmaceuticals Pvt. Ltd.
Gland Pharma Limited
Troikaa Pharmaceuticals Ltd.
Biological E Limited
Bharat Biotech
Samarth Life Sciences Pvt. Ltd.
VHB Life Sciences Limited
Celon Laboratories Pvt. Ltd.
United Biotech(P) Limited
Segment by Type
Insulin
Teriparatide
Liraglutide
Leuprolide

Segment by Application


Diabetes
Infectious Diseases
Cancer
Osteoporosis

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Peptides market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Peptides, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Peptides industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Peptides in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Peptides introduction, etc. Peptides Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Peptides market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Peptides Market Overview
1.1 Peptides Product Overview
1.2 Peptides Market Segment by Type
1.2.1 Insulin
1.2.2 Teriparatide
1.2.3 Liraglutide
1.2.4 Leuprolide
1.3 Global Peptides Market Size by Type
1.3.1 Global Peptides Market Size Overview by Type (2018-2034)
1.3.2 Global Peptides Historic Market Size Review by Type (2018-2024)
1.3.3 Global Peptides Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Peptides Sales Breakdown by Type (2018-2024)
1.4.2 Europe Peptides Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Peptides Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Peptides Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Peptides Sales Breakdown by Type (2018-2024)
2 Global Peptides Market Competition by Company
2.1 Global Top Players by Peptides Sales (2018-2024)
2.2 Global Top Players by Peptides Revenue (2018-2024)
2.3 Global Top Players by Peptides Price (2018-2024)
2.4 Global Top Manufacturers Peptides Manufacturing Base Distribution, Sales Area, Product Type
2.5 Peptides Market Competitive Situation and Trends
2.5.1 Peptides Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Peptides Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Peptides as of 2022)
2.7 Date of Key Manufacturers Enter into Peptides Market
2.8 Key Manufacturers Peptides Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Peptides Status and Outlook by Region
3.1 Global Peptides Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Peptides Historic Market Size by Region
3.2.1 Global Peptides Sales in Volume by Region (2018-2024)
3.2.2 Global Peptides Sales in Value by Region (2018-2024)
3.2.3 Global Peptides Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Peptides Forecasted Market Size by Region
3.3.1 Global Peptides Sales in Volume by Region (2024-2034)
3.3.2 Global Peptides Sales in Value by Region (2024-2034)
3.3.3 Global Peptides Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Peptides by Application
4.1 Peptides Market Segment by Application
4.1.1 Diabetes
4.1.2 Infectious Diseases
4.1.3 Cancer
4.1.4 Osteoporosis
4.2 Global Peptides Market Size by Application
4.2.1 Global Peptides Market Size Overview by Application (2018-2034)
4.2.2 Global Peptides Historic Market Size Review by Application (2018-2024)
4.2.3 Global Peptides Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Peptides Sales Breakdown by Application (2018-2024)
4.3.2 Europe Peptides Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Peptides Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Peptides Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Peptides Sales Breakdown by Application (2018-2024)
5 North America Peptides by Country
5.1 North America Peptides Historic Market Size by Country
5.1.1 North America Peptides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Peptides Sales in Volume by Country (2018-2024)
5.1.3 North America Peptides Sales in Value by Country (2018-2024)
5.2 North America Peptides Forecasted Market Size by Country
5.2.1 North America Peptides Sales in Volume by Country (2024-2034)
5.2.2 North America Peptides Sales in Value by Country (2024-2034)
6 Europe Peptides by Country
6.1 Europe Peptides Historic Market Size by Country
6.1.1 Europe Peptides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Peptides Sales in Volume by Country (2018-2024)
6.1.3 Europe Peptides Sales in Value by Country (2018-2024)
6.2 Europe Peptides Forecasted Market Size by Country
6.2.1 Europe Peptides Sales in Volume by Country (2024-2034)
6.2.2 Europe Peptides Sales in Value by Country (2024-2034)
7 Asia-Pacific Peptides by Region
7.1 Asia-Pacific Peptides Historic Market Size by Region
7.1.1 Asia-Pacific Peptides Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Peptides Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Peptides Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Peptides Forecasted Market Size by Region
7.2.1 Asia-Pacific Peptides Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Peptides Sales in Value by Region (2024-2034)
8 Latin America Peptides by Country
8.1 Latin America Peptides Historic Market Size by Country
8.1.1 Latin America Peptides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Peptides Sales in Volume by Country (2018-2024)
8.1.3 Latin America Peptides Sales in Value by Country (2018-2024)
8.2 Latin America Peptides Forecasted Market Size by Country
8.2.1 Latin America Peptides Sales in Volume by Country (2024-2034)
8.2.2 Latin America Peptides Sales in Value by Country (2024-2034)
9 Middle East and Africa Peptides by Country
9.1 Middle East and Africa Peptides Historic Market Size by Country
9.1.1 Middle East and Africa Peptides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Peptides Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Peptides Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Peptides Forecasted Market Size by Country
9.2.1 Middle East and Africa Peptides Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Peptides Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Cipla Ltd.
10.1.1 Cipla Ltd. Company Information
10.1.2 Cipla Ltd. Introduction and Business Overview
10.1.3 Cipla Ltd. Peptides Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Cipla Ltd. Peptides Products Offered
10.1.5 Cipla Ltd. Recent Development
10.2 Emcure Pharmaceuticals Pvt. Ltd.
10.2.1 Emcure Pharmaceuticals Pvt. Ltd. Company Information
10.2.2 Emcure Pharmaceuticals Pvt. Ltd. Introduction and Business Overview
10.2.3 Emcure Pharmaceuticals Pvt. Ltd. Peptides Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Emcure Pharmaceuticals Pvt. Ltd. Peptides Products Offered
10.2.5 Emcure Pharmaceuticals Pvt. Ltd. Recent Development
10.3 Gland Pharma Limited
10.3.1 Gland Pharma Limited Company Information
10.3.2 Gland Pharma Limited Introduction and Business Overview
10.3.3 Gland Pharma Limited Peptides Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Gland Pharma Limited Peptides Products Offered
10.3.5 Gland Pharma Limited Recent Development
10.4 Troikaa Pharmaceuticals Ltd.
10.4.1 Troikaa Pharmaceuticals Ltd. Company Information
10.4.2 Troikaa Pharmaceuticals Ltd. Introduction and Business Overview
10.4.3 Troikaa Pharmaceuticals Ltd. Peptides Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Troikaa Pharmaceuticals Ltd. Peptides Products Offered
10.4.5 Troikaa Pharmaceuticals Ltd. Recent Development
10.5 Biological E Limited
10.5.1 Biological E Limited Company Information
10.5.2 Biological E Limited Introduction and Business Overview
10.5.3 Biological E Limited Peptides Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Biological E Limited Peptides Products Offered
10.5.5 Biological E Limited Recent Development
10.6 Bharat Biotech
10.6.1 Bharat Biotech Company Information
10.6.2 Bharat Biotech Introduction and Business Overview
10.6.3 Bharat Biotech Peptides Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Bharat Biotech Peptides Products Offered
10.6.5 Bharat Biotech Recent Development
10.7 Samarth Life Sciences Pvt. Ltd.
10.7.1 Samarth Life Sciences Pvt. Ltd. Company Information
10.7.2 Samarth Life Sciences Pvt. Ltd. Introduction and Business Overview
10.7.3 Samarth Life Sciences Pvt. Ltd. Peptides Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Samarth Life Sciences Pvt. Ltd. Peptides Products Offered
10.7.5 Samarth Life Sciences Pvt. Ltd. Recent Development
10.8 VHB Life Sciences Limited
10.8.1 VHB Life Sciences Limited Company Information
10.8.2 VHB Life Sciences Limited Introduction and Business Overview
10.8.3 VHB Life Sciences Limited Peptides Sales, Revenue and Gross Margin (2018-2024)
10.8.4 VHB Life Sciences Limited Peptides Products Offered
10.8.5 VHB Life Sciences Limited Recent Development
10.9 Celon Laboratories Pvt. Ltd.
10.9.1 Celon Laboratories Pvt. Ltd. Company Information
10.9.2 Celon Laboratories Pvt. Ltd. Introduction and Business Overview
10.9.3 Celon Laboratories Pvt. Ltd. Peptides Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Celon Laboratories Pvt. Ltd. Peptides Products Offered
10.9.5 Celon Laboratories Pvt. Ltd. Recent Development
10.10 United Biotech(P) Limited
10.10.1 United Biotech(P) Limited Company Information
10.10.2 United Biotech(P) Limited Introduction and Business Overview
10.10.3 United Biotech(P) Limited Peptides Sales, Revenue and Gross Margin (2018-2024)
10.10.4 United Biotech(P) Limited Peptides Products Offered
10.10.5 United Biotech(P) Limited Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Peptides Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Peptides Industrial Chain Analysis
11.4 Peptides Market Dynamics
11.4.1 Peptides Industry Trends
11.4.2 Peptides Market Drivers
11.4.3 Peptides Market Challenges
11.4.4 Peptides Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Peptides Distributors
12.3 Peptides Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Insulin
Table 2. Major Company of Teriparatide
Table 3. Major Company of Liraglutide
Table 4. Major Company of Leuprolide
Table 5. Global Peptides Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Peptides Sales by Type (2018-2024) & (K Pcs)
Table 7. Global Peptides Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Peptides Sales by Type (2018-2024) & (US& Million)
Table 9. Global Peptides Market Share in Value by Type (2018-2024)
Table 10. Global Peptides Price by Type (2018-2024) & (USD/Pcs)
Table 11. Global Peptides Sales by Type (2024-2034) & (K Pcs)
Table 12. Global Peptides Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Peptides Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Peptides Sales Market Share in Value by Type (2024-2034)
Table 15. Global Peptides Price by Type (2024-2034) & (USD/Pcs)
Table 16. North America Peptides Sales by Type (2018-2024) & (K Pcs)
Table 17. North America Peptides Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Peptides Sales (K Pcs) by Type (2018-2024)
Table 19. Europe Peptides Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Peptides Sales (K Pcs) by Type (2018-2024)
Table 21. Asia-Pacific Peptides Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Peptides Sales (K Pcs) by Type (2018-2024)
Table 23. Latin America Peptides Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Peptides Sales (K Pcs) by Type (2018-2024)
Table 25. Middle East and Africa Peptides Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Peptides Sales by Company (2018-2024) & (K Pcs)
Table 27. Global Peptides Sales Share by Company (2018-2024)
Table 28. Global Peptides Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Peptides Revenue Share by Company (2018-2024)
Table 30. Global Market Peptides Price by Company (2018-2024) & (USD/Pcs)
Table 31. Global Peptides Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Peptides Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Peptides as of 2022)
Table 34. Date of Key Manufacturers Enter into Peptides Market
Table 35. Key Manufacturers Peptides Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Peptides Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Peptides Sales by Region (2018-2024) & (K Pcs)
Table 39. Global Peptides Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Peptides Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Peptides Sales Market Share in Value by Region (2018-2024)
Table 42. Global Peptides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 43. Global Peptides Sales by Region (2024-2034) & (K Pcs)
Table 44. Global Peptides Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Peptides Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Peptides Sales Market Share in Value by Region (2024-2034)
Table 47. Global Peptides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 48. Global Peptides Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Peptides Sales by Application (2018-2024) & (K Pcs)
Table 50. Global Peptides Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Peptides Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Peptides Sales Market Share in Value by Application (2018-2024)
Table 53. Global Peptides Price by Application (2018-2024) & (USD/Pcs)
Table 54. Global Peptides Sales by Application (2024-2034) & (K Pcs)
Table 55. Global Peptides Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Peptides Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Peptides Sales Market Share in Value by Application (2024-2034)
Table 58. Global Peptides Price by Application (2024-2034) & (USD/Pcs)
Table 59. North America Peptides Sales by Application (2018-2024) (K Pcs)
Table 60. North America Peptides Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Peptides Sales by Application (2018-2024) (K Pcs)
Table 62. Europe Peptides Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Peptides Sales by Application (2018-2024) (K Pcs)
Table 64. Asia-Pacific Peptides Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Peptides Sales by Application (2018-2024) (K Pcs)
Table 66. Latin America Peptides Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Peptides Sales by Application (2018-2024) (K Pcs)
Table 68. Middle East and Africa Peptides Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Peptides Sales by Country (2018-2024) & (K Pcs)
Table 70. North America Peptides Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Peptides Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Peptides Sales Market Share in Value by Country (2018-2024)
Table 73. North America Peptides Sales by Country (2024-2034) & (K Pcs)
Table 74. North America Peptides Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Peptides Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Peptides Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Peptides Sales by Country (2018-2024) & (K Pcs)
Table 78. Europe Peptides Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Peptides Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Peptides Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Peptides Sales by Country (2024-2034) & (K Pcs)
Table 82. Europe Peptides Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Peptides Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Peptides Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Peptides Sales by Region (2018-2024) & (K Pcs)
Table 86. Asia-Pacific Peptides Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Peptides Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Peptides Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Peptides Sales by Region (2024-2034) & (K Pcs)
Table 90. Asia-Pacific Peptides Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Peptides Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Peptides Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Peptides Sales by Country (2018-2024) & (K Pcs)
Table 94. Latin America Peptides Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Peptides Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Peptides Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Peptides Sales by Country (2024-2034) & (K Pcs)
Table 98. Latin America Peptides Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Peptides Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Peptides Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Peptides Sales by Country (2018-2024) & (K Pcs)
Table 102. Middle East and Africa Peptides Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Peptides Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Peptides Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Peptides Sales by Country (2024-2034) & (K Pcs)
Table 106. Middle East and Africa Peptides Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Peptides Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Peptides Sales Market Share in Value by Country (2024-2034)
Table 109. Cipla Ltd. Company Information
Table 110. Cipla Ltd. Introduction and Business Overview
Table 111. Cipla Ltd. Peptides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 112. Cipla Ltd. Peptides Product
Table 113. Cipla Ltd. Recent Development
Table 114. Emcure Pharmaceuticals Pvt. Ltd. Company Information
Table 115. Emcure Pharmaceuticals Pvt. Ltd. Introduction and Business Overview
Table 116. Emcure Pharmaceuticals Pvt. Ltd. Peptides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 117. Emcure Pharmaceuticals Pvt. Ltd. Peptides Product
Table 118. Emcure Pharmaceuticals Pvt. Ltd. Recent Development
Table 119. Gland Pharma Limited Company Information
Table 120. Gland Pharma Limited Introduction and Business Overview
Table 121. Gland Pharma Limited Peptides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 122. Gland Pharma Limited Peptides Product
Table 123. Gland Pharma Limited Recent Development
Table 124. Troikaa Pharmaceuticals Ltd. Company Information
Table 125. Troikaa Pharmaceuticals Ltd. Introduction and Business Overview
Table 126. Troikaa Pharmaceuticals Ltd. Peptides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 127. Troikaa Pharmaceuticals Ltd. Peptides Product
Table 128. Troikaa Pharmaceuticals Ltd. Recent Development
Table 129. Biological E Limited Company Information
Table 130. Biological E Limited Introduction and Business Overview
Table 131. Biological E Limited Peptides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 132. Biological E Limited Peptides Product
Table 133. Biological E Limited Recent Development
Table 134. Bharat Biotech Company Information
Table 135. Bharat Biotech Introduction and Business Overview
Table 136. Bharat Biotech Peptides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 137. Bharat Biotech Peptides Product
Table 138. Bharat Biotech Recent Development
Table 139. Samarth Life Sciences Pvt. Ltd. Company Information
Table 140. Samarth Life Sciences Pvt. Ltd. Introduction and Business Overview
Table 141. Samarth Life Sciences Pvt. Ltd. Peptides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 142. Samarth Life Sciences Pvt. Ltd. Peptides Product
Table 143. Samarth Life Sciences Pvt. Ltd. Recent Development
Table 144. VHB Life Sciences Limited Company Information
Table 145. VHB Life Sciences Limited Introduction and Business Overview
Table 146. VHB Life Sciences Limited Peptides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 147. VHB Life Sciences Limited Peptides Product
Table 148. VHB Life Sciences Limited Recent Development
Table 149. Celon Laboratories Pvt. Ltd. Company Information
Table 150. Celon Laboratories Pvt. Ltd. Introduction and Business Overview
Table 151. Celon Laboratories Pvt. Ltd. Peptides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 152. Celon Laboratories Pvt. Ltd. Peptides Product
Table 153. Celon Laboratories Pvt. Ltd. Recent Development
Table 154. United Biotech(P) Limited Company Information
Table 155. United Biotech(P) Limited Introduction and Business Overview
Table 156. United Biotech(P) Limited Peptides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 157. United Biotech(P) Limited Peptides Product
Table 158. United Biotech(P) Limited Recent Development
Table 159. Key Raw Materials Lists
Table 160. Raw Materials Key Suppliers Lists
Table 161. Peptides Market Trends
Table 162. Peptides Market Drivers
Table 163. Peptides Market Challenges
Table 164. Peptides Market Restraints
Table 165. Peptides Distributors List
Table 166. Peptides Downstream Customers
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Peptides Product Picture
Figure 2. Global Peptides Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Peptides Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Peptides Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Insulin
Figure 6. Global Insulin Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Teriparatide
Figure 8. Global Teriparatide Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of Liraglutide
Figure 10. Global Liraglutide Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Leuprolide
Figure 12. Global Leuprolide Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Global Peptides Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Peptides Sales Market Share by Type in 2022 & 2034
Figure 15. North America Peptides Sales Market Share in Volume by Type in 2022
Figure 16. North America Peptides Sales Market Share in Value by Type in 2022
Figure 17. Europe Peptides Sales Market Share in Volume by Type in 2022
Figure 18. Europe Peptides Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Peptides Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Peptides Sales Market Share in Value by Type in 2022
Figure 21. Latin America Peptides Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Peptides Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Peptides Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Peptides Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Peptides Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Peptides Revenue in 2022
Figure 27. Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Diabetes
Figure 29. Global Diabetes Sales YoY Growth (2018-2034) & (K Pcs)
Figure 30. Product Picture of Infectious Diseases
Figure 31. Global Infectious Diseases Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Cancer
Figure 33. Global Cancer Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Osteoporosis
Figure 35. Global Osteoporosis Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Global Peptides Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global Peptides Sales Market Share by Application in 2022 & 2034
Figure 38. North America Peptides Sales Market Share in Volume by Application in 2022
Figure 39. North America Peptides Sales Market Share in Value by Application in 2022
Figure 40. Europe Peptides Sales Market Share in Volume by Application in 2022
Figure 41. Europe Peptides Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Peptides Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Peptides Sales Market Share in Value by Application in 2022
Figure 44. Latin America Peptides Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Peptides Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Peptides Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Peptides Manufacturing Cost Structure
Figure 49. Peptides Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed